AVALO THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
AVALO THERAPEUTICS, INC. (AVTX) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-23
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2025-12-31 was $0.00.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2025-09-30 was $0.00.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2025-06-30 was $0.00.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2024 was $115.63M.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2023 was $0.00.
- AVALO THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 3 month as first filed | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 6 month as first filed | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 9 month as first filed | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-23 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 derived: sum of 4 quarters · filed 2026-03-23 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 derived: sum of 4 quarters · filed 2026-03-23 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $115.63M 10-K · filed 2026-03-23 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $115.63M 10-Q · filed 2025-11-06 | $115.63M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $115.63M 10-Q · filed 2025-08-07 | $115.63M derived: sum of 3 quarters · filed 2025-08-07 | $115.63M derived: sum of 4 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | $115.63M 10-Q · filed 2025-05-12 | $115.63M derived: sum of 2 quarters · filed 2025-05-12 | $115.63M derived: sum of 3 quarters · filed 2025-05-12 | $115.63M derived: sum of 4 quarters · filed 2025-05-12 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | |||||||
| 2023-03-31 | $0.00 10-Q/A · filed 2024-07-11 | ||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $0.00 derived: sum of 2 quarters · filed 2022-03-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $0.00 10-K · filed 2022-03-02 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-02 | |||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $0.00 10-Q · filed 2021-08-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $0.00 derived: sum of 4 quarters · filed 2022-03-02 | |||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $0.00 derived: sum of 4 quarters · filed 2022-03-02 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $0.00 derived: sum of 2 quarters · filed 2022-03-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $3.89M 10-K · filed 2022-03-02 | $3.89M 10-K · filed 2021-03-08 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $3.89M 10-Q · filed 2021-11-09 | $3.89M 10-Q · filed 2020-11-09 | $3.86M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $3.89M 10-Q · filed 2021-08-02 | $3.89M 10-Q · filed 2020-08-06 | $3.86M derived: sum of 3 quarters · filed 2021-08-02 | $7.60M derived: sum of 4 quarters · filed 2021-08-02 | ||||
| 2020-03-31 | $3.89M 10-Q · filed 2021-05-13 | $3.89M 10-Q · filed 2020-05-07 | $3.86M derived: sum of 2 quarters · filed 2021-05-13 | $7.60M derived: sum of 3 quarters · filed 2021-05-13 | $7.60M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$28.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $3.71M derived: sum of 2 quarters · filed 2021-03-08 | $3.71M derived: sum of 3 quarters · filed 2021-03-08 | $3.71M 10-K · filed 2021-03-08 | |||||
| 2019-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.74M derived: sum of 2 quarters · filed 2020-11-09 | $3.74M 10-Q · filed 2020-11-09 | $3.74M derived: sum of 4 quarters · filed 2020-11-09 | |||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-08-06 | $3.86M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-05-07 | $3.86M derived: sum of 3 quarters · filed 2020-05-07 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $3.86M derived: sum of 2 quarters · filed 2020-03-11 | $3.86M 10-K · filed 2020-03-11 | ||||||
| 2018-09-30 | $3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.86M 10-Q · filed 2019-11-14 | |||||||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | ||||||||
| 2017-12-31 | -$4.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$4.00 derived: sum of 2 quarters · filed 2019-03-18 | $4.65M 10-K · filed 2019-03-18 | ||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $4.65M 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | $4.65M 10-Q · filed 2018-08-09 | ||||||||
| 2017-04-30 | $5.00M 10-Q · filed 2017-11-07 | ||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | ||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | ||||||||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |